127 related articles for article (PubMed ID: 35753135)
1. Nav1.6 promotes the progression of human follicular thyroid carcinoma cells via JAK-STAT signaling pathway.
Li H; Liu J; Fan N; Wang H; Thomas AM; Yan Q; Li S; Qin H
Pathol Res Pract; 2022 Aug; 236():153984. PubMed ID: 35753135
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract][Full Text] [Related]
3. Crocin treatment promotes the oxidative stress and apoptosis in human thyroid cancer cells FTC-133 through the inhibition of STAT/JAK signaling pathway.
Zhang Y; Zhu M; Krishna Mohan S; Hao Z
J Biochem Mol Toxicol; 2021 Jan; 35(1):e22608. PubMed ID: 32886819
[TBL] [Abstract][Full Text] [Related]
4. SRRM1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the JAK/STAT signaling pathway.
Song X; Ma J
Tissue Cell; 2022 Dec; 79():101954. PubMed ID: 36270072
[TBL] [Abstract][Full Text] [Related]
5. Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.
Limberg J; Egan CE; Gray KD; Singh M; Loewenstein Z; Yang Y; Riascos MC; Al Asadi H; Safe P; El Eshaky S; Liang H; Ullmann TM; Wang W; Li W; Zhang T; Xiang J; Stefanova D; Jin MM; Zarnegar R; Fahey TJ; Min IM
Mol Cancer Res; 2023 May; 21(5):397-410. PubMed ID: 36790391
[TBL] [Abstract][Full Text] [Related]
6. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
Groner B; von Manstein V
Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
[TBL] [Abstract][Full Text] [Related]
7. The miR-199a-5p/PD-L1 axis regulates cell proliferation, migration and invasion in follicular thyroid carcinoma.
Lin J; Qiu Y; Zheng X; Dai Y; Xu T
BMC Cancer; 2022 Jul; 22(1):756. PubMed ID: 35818041
[TBL] [Abstract][Full Text] [Related]
8. The role of CD147 in the invasiveness of follicular thyroid carcinoma cells.
Omi Y; Shibata N; Okamoto T; Obara T; Kobayashi M
Thyroid; 2012 Apr; 22(4):383-94. PubMed ID: 22280229
[TBL] [Abstract][Full Text] [Related]
9. FUT7 promotes the malignant transformation of follicular thyroid carcinoma through α1,3-fucosylation of EGF receptor.
Qin H; Liu J; Yu M; Wang H; Thomas AM; Li S; Yan Q; Wang L
Exp Cell Res; 2020 Aug; 393(2):112095. PubMed ID: 32442537
[TBL] [Abstract][Full Text] [Related]
10. miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4.
Ma W; Zhao X; Liang L; Wang G; Li Y; Miao X; Zhao Y
Oncotarget; 2017 Apr; 8(17):28028-28041. PubMed ID: 28427206
[TBL] [Abstract][Full Text] [Related]
11. JAK-STAT and AKT pathway-coupled genes in erythroid progenitor cells through ontogeny.
Cokic VP; Bhattacharya B; Beleslin-Cokic BB; Noguchi CT; Puri RK; Schechter AN
J Transl Med; 2012 Jun; 10():116. PubMed ID: 22676255
[TBL] [Abstract][Full Text] [Related]
12. The JAK/STAT signaling cascade in gastric carcinoma (Review).
Khanna P; Chua PJ; Bay BH; Baeg GH
Int J Oncol; 2015 Nov; 47(5):1617-26. PubMed ID: 26398764
[TBL] [Abstract][Full Text] [Related]
13. The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness.
Zwanziger D; Badziong J; Ting S; Moeller LC; Schmid KW; Siebolts U; Wickenhauser C; Dralle H; Fuehrer D
Endocr Relat Cancer; 2015 Oct; 22(5):819-30. PubMed ID: 26219679
[TBL] [Abstract][Full Text] [Related]
14. ETV5 overexpression contributes to tumor growth and progression of thyroid cancer through PIK3CA.
Meng D; Li Z; Ma X; Wu L; Fu L; Qin G
Life Sci; 2020 Jul; 253():117693. PubMed ID: 32325133
[TBL] [Abstract][Full Text] [Related]
15. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
Lu J; Zhang L; Zhou H; Du Z; Zhang G
Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
[TBL] [Abstract][Full Text] [Related]
16. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
17. Anoctamin5 regulates cell migration and invasion in thyroid cancer.
Chang Z; Cai C; Han D; Gao Y; Li Q; Feng L; Zhang W; Zheng J; Jin J; Zhang H; Wei Q
Int J Oncol; 2017 Oct; 51(4):1311-1319. PubMed ID: 28902351
[TBL] [Abstract][Full Text] [Related]
18. Low-Density Lipoprotein Contributes to Endometrial Carcinoma Cell Proliferation, Migration, and Invasion by Activating the JAK-STAT Signaling Pathway.
Shen L; Zhang C; Cui K; Liang X; Zhu G
Anal Cell Pathol (Amst); 2023; 2023():4015167. PubMed ID: 37900720
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA GAS5 Targeting miR-221-3p/Cyclin-Dependent Kinase Inhibitor 2B Axis Regulates Follicular Thyroid Carcinoma Cell Cycle and Proliferation.
Liu Y; Li YF; Liu J; Deng ZG; Zeng L; Zhou WB
Pathobiology; 2021; 88(4):289-300. PubMed ID: 34130294
[TBL] [Abstract][Full Text] [Related]
20. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway.
Xu CH; Liu Y; Xiao LM; Chen LK; Zheng SY; Zeng EM; Li DH; Li YP
J Cell Physiol; 2019 Dec; 234(12):22272-22284. PubMed ID: 31106423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
